Therapeutic peptides: Historical perspectives, current development trends, and future directions
- PMID: 28720325
- DOI: 10.1016/j.bmc.2017.06.052
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Abstract
Peptide therapeutics have played a notable role in medical practice since the advent of insulin therapy in the 1920s. Over 60 peptide drugs are approved in the United States and other major markets, and peptides continue to enter clinical development at a steady pace. Peptide drug discovery has diversified beyond its traditional focus on endogenous human peptides to include a broader range of structures identified from other natural sources or through medicinal chemistry efforts. We maintain a comprehensive dataset on peptides that have entered human clinical studies that includes over 150 peptides in active development today. Here we provide an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown.
Keywords: Clinical development; Drug discovery; Drugs; G protein-coupled receptors; Peptides.
Copyright © 2017. Published by Elsevier Ltd.
Similar articles
-
Pharmacology and therapeutic potential of venom peptides.Biochem Pharmacol. 2020 Nov;181:114207. doi: 10.1016/j.bcp.2020.114207. Epub 2020 Aug 26. Biochem Pharmacol. 2020. PMID: 32857993 No abstract available.
-
Peptide therapeutics from venom: Current status and potential.Bioorg Med Chem. 2018 Jun 1;26(10):2738-2758. doi: 10.1016/j.bmc.2017.09.029. Epub 2017 Sep 23. Bioorg Med Chem. 2018. PMID: 28988749 Review.
-
Protein and Peptide Biopharmaceuticals: An Overview.Protein Pept Lett. 2017;24(2):94-101. doi: 10.2174/0929866523666161222150444. Protein Pept Lett. 2017. PMID: 28017145 Review.
-
Future directions for peptide therapeutics development.Drug Discov Today. 2013 Sep;18(17-18):807-17. doi: 10.1016/j.drudis.2013.05.011. Epub 2013 May 28. Drug Discov Today. 2013. PMID: 23726889 Review.
-
Current trends in the clinical development of peptide therapeutics.IDrugs. 2009 Dec;12(12):779-84. IDrugs. 2009. PMID: 19943221 Review.
Cited by
-
A production platform for disulfide-bonded peptides in the periplasm of Escherichia coli.Microb Cell Fact. 2024 Jun 5;23(1):166. doi: 10.1186/s12934-024-02446-6. Microb Cell Fact. 2024. PMID: 38840157 Free PMC article.
-
HelixDiff, a Score-Based Diffusion Model for Generating All-Atom α-Helical Structures.ACS Cent Sci. 2024 Apr 5;10(5):1001-1011. doi: 10.1021/acscentsci.3c01488. eCollection 2024 May 22. ACS Cent Sci. 2024. PMID: 38799672 Free PMC article.
-
Synthesis of the Antimicrobial Peptide Murepavadin Using Novel Coupling Agents.Biomolecules. 2024 Apr 27;14(5):526. doi: 10.3390/biom14050526. Biomolecules. 2024. PMID: 38785933 Free PMC article.
-
Efficient screening of pharmacological broad-spectrum anti-cancer peptides utilizing advanced bidirectional Encoder representation from Transformers strategy.Heliyon. 2024 May 1;10(9):e30373. doi: 10.1016/j.heliyon.2024.e30373. eCollection 2024 May 15. Heliyon. 2024. PMID: 38765108 Free PMC article.
-
Squaric esters as peptide stapling reagents.Tetrahedron Lett. 2024 Apr 28;140:155010. doi: 10.1016/j.tetlet.2024.155010. Epub 2024 Mar 29. Tetrahedron Lett. 2024. PMID: 38736688
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources